Please provide your email address to receive an email when new articles are posted on . The slow march toward precision medicine in rheumatoid arthritis features increased use of serum biomarkers and ...

HAYWARD, Calif.--(BUSINESS WIRE)--Aqtual, Inc., a precision medicine company with a novel active chromatin cell-free DNA (cfDNA ac) platform to develop products for chronic diseases and oncology, ...